VTE risk scoring and prophylaxis prescription on admission by differences in VTE risk stratification between admitting providers and the SME
| . | Discordant high∗ (N = 1156) . | Discordant low† (N = 240) . | Concordant high (N = 818) . | Concordant low (N = 1807) . |
|---|---|---|---|---|
| Median Padua score (IQR) | ||||
| Expert | 4 (4-5) | 1 (1-2) | 5 (4-7) | 1 (1-2) |
| Prescriber | 1 (0-1) | 3 (3-4) | 4 (3-5) | 1 (0-1) |
| Prophylaxis prescribed, n (%) | ||||
| Heparin 5000 u q8h | 325 (28.1) | 70 (29.2) | 208 (25.4) | 383 (21.2) |
| Heparin 5000 u q12h | 33 (2.9) | 11 (4.6) | 32 (3.9) | 32 (1.8) |
| Enoxaparin 40 mg q24h | 259 (22.4) | 96 (40.0) | 208 (25.4) | 473 (26.2) |
| Other prophylaxis | 8 (0.7) | 3 (1.3) | 10 (1.2) | 16 (0.9) |
| Mechanical prophylaxis only | 124 (10.7) | 23 (9.6) | 79 (9.7) | 231 (12.8) |
| Therapeutic AC | 138 (11.9) | 28 (11.7) | 196 (24.0) | 154 (8.5) |
| No prophylaxis | 269 (23.3) | 9 (3.8) | 85 (10.4) | 518 (28.7) |
| Pharmacologic prophylaxis contraindication, n (%) | 231 (20.0) | 63 (26.3) | 365 (44.6) | 326 (18.0) |
| Prescribed pharmacologic prophylaxis, n (%) | 625 (54.1) | 180 (75.0) | 458 (56.0) | 904 (50.0) |
| Prescription compliance, n (%) | 777 (67.2) | 33 (13.8) | 667 (81.5) | 664 (36.7) |
| . | Discordant high∗ (N = 1156) . | Discordant low† (N = 240) . | Concordant high (N = 818) . | Concordant low (N = 1807) . |
|---|---|---|---|---|
| Median Padua score (IQR) | ||||
| Expert | 4 (4-5) | 1 (1-2) | 5 (4-7) | 1 (1-2) |
| Prescriber | 1 (0-1) | 3 (3-4) | 4 (3-5) | 1 (0-1) |
| Prophylaxis prescribed, n (%) | ||||
| Heparin 5000 u q8h | 325 (28.1) | 70 (29.2) | 208 (25.4) | 383 (21.2) |
| Heparin 5000 u q12h | 33 (2.9) | 11 (4.6) | 32 (3.9) | 32 (1.8) |
| Enoxaparin 40 mg q24h | 259 (22.4) | 96 (40.0) | 208 (25.4) | 473 (26.2) |
| Other prophylaxis | 8 (0.7) | 3 (1.3) | 10 (1.2) | 16 (0.9) |
| Mechanical prophylaxis only | 124 (10.7) | 23 (9.6) | 79 (9.7) | 231 (12.8) |
| Therapeutic AC | 138 (11.9) | 28 (11.7) | 196 (24.0) | 154 (8.5) |
| No prophylaxis | 269 (23.3) | 9 (3.8) | 85 (10.4) | 518 (28.7) |
| Pharmacologic prophylaxis contraindication, n (%) | 231 (20.0) | 63 (26.3) | 365 (44.6) | 326 (18.0) |
| Prescribed pharmacologic prophylaxis, n (%) | 625 (54.1) | 180 (75.0) | 458 (56.0) | 904 (50.0) |
| Prescription compliance, n (%) | 777 (67.2) | 33 (13.8) | 667 (81.5) | 664 (36.7) |